04 Nov Laurens Kruidenier
Laurens Kruidenier Chief Scientific Officer at Nilo Therapeutics, Dr. Kruidenier is an accomplished immunology and drug discovery leader. He previously served as CSO at Cellarity and at Prometheus Biosciences (acquired by Merck), where he advanced multiple innovative therapies from concept to clinic in autoimmune and inflammatory...